ICAD INC. - COMMON STO

iCAD Announces CEO Transition

06 Dec 2021 07:00:02 By Nasdaq GlobeNewswire

iCAD Announces Compelling New and Real-World Data Demonstrating the Value of ProFound AI to be Presented at RSNA 2021

29 Nov 2021 07:00:01 By Nasdaq GlobeNewswire

iCAD to Participate in the 12th Annual Craig-Hallum Alpha Select Conference

11 Nov 2021 15:05:01 By Nasdaq GlobeNewswire

iCAD to Host 2nd Annual Virtual Investor Webinar on Company’s Innovative Solutions for Cancer Detection and Treatment

11 Nov 2021 07:00:02 By Nasdaq GlobeNewswire

iCAD Reports Financial Results for the Quarter Ended September 30, 2021

09 Nov 2021 15:05:01 By Nasdaq GlobeNewswire

iCAD to Report Third Quarter 2021 Financial Results on Tuesday, November 9

26 Oct 2021 07:00:03 By Nasdaq GlobeNewswire

iCAD Unveils Next Generation Technologies at Journées Francophones de Radiologie (October 8-11, Paris, France)

07 Oct 2021 07:00:01 By Nasdaq GlobeNewswire

iCAD Launches Revolutionary Short-term Personalized Risk Assessment Solution for 3D Mammography

29 Sep 2021 07:00:01 By Nasdaq GlobeNewswire

iCAD to Host Educational Roundtable to Help Clinicians and Facilities Recover from COVID-19 Impact

09 Sep 2021 13:46:04 By Nasdaq GlobeNewswire

iCAD’s Xoft Brain IORT Demonstrates Significant Improvement in Overall Survival in Recurrent Glioblastoma According to Comparative Study

31 Aug 2021 07:00:01 By Nasdaq GlobeNewswire

iCAD Reports Financial Results for the Quarter Ended June 30, 2021

05 Aug 2021 15:01:02 By Nasdaq GlobeNewswire

iCAD to Participate in the Guggenheim MedTech Disruptors Summit

02 Aug 2021 15:05:01 By Nasdaq GlobeNewswire

iCAD to Report Second Quarter 2021 Financial Results on Thursday, August 5

22 Jul 2021 15:01:00 By Nasdaq GlobeNewswire

iCAD’s ProFound AI for Digital Breast Tomosynthesis Version 3.0 Receives CE Mark Approval

14 Jun 2021 07:00:01 By Nasdaq GlobeNewswire

iCAD Signs Global Distribution Agreement with Sectra

08 Jun 2021 07:00:01 By Nasdaq GlobeNewswire

iCAD to Participate in Upcoming Virtual Investor Conferences

17 May 2021 15:05:01 By Nasdaq GlobeNewswire

iCAD Announces Educational Webinar Featuring Leading Global Experts Discussing New Multidisciplinary Approach for Treating Brain Tumors, May 25

17 May 2021 07:00:02 By Nasdaq GlobeNewswire

iCAD Reports Financial Results for First Quarter Ended March 31, 2021

28 Apr 2021 15:01:00 By Nasdaq GlobeNewswire

iCAD to Report First Quarter 2021 Financial Results on Wednesday, April 28

20 Apr 2021 15:01:00 By Nasdaq GlobeNewswire

New Research Confirms iCAD’s ProFound AI Aids Breast Cancer Detection with Digital Breast Tomosynthesis, Improves Radiologists’ Workflow

19 Apr 2021 07:00:01 By Nasdaq GlobeNewswire